Results 221 to 230 of about 9,672 (236)

Perioperative Ledipasvir–Sofosbuvir for HCV in Liver-Transplant Recipients

New England Journal of Medicine, 2016
Josh Levitsky, Elizabeth C Verna
exaly  

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

New England Journal of Medicine, 2015
Susanna Naggie, Edward Gane, Polina German   +2 more
exaly  

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Lancet Infectious Diseases, The, 2016
Michael Manns, Didier Samuel, Maria Buti
exaly  

Retreatment efficacy and predictors of ledipasvir plus sofosbuvir to HCV genotype 1 in Japan

Journal of Medical Virology, 2017
Norio Akuta, Hitomi Sezaki, Yusuke Kawamura   +2 more
exaly  

A facile synthesis of 3D NiFe2O4 nanospheres anchored on a novel ionic liquid modified reduced graphene oxide for electrochemical sensing of ledipasvir: Application to human pharmacokinetic study

Biosensors and Bioelectronics, 2018
Ashraf M Mahmoud, Saad A Alkahtani, Adel A Marzouk   +2 more
exaly  

Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)

Lancet Infectious Diseases, The, 2015
Christophe Hézode, Fabien Zoulim, Philippe Mathurin   +2 more
exaly  

Effectiveness of Ledipasvir-Sofosbuvir Combination in Patients With Hepatitis C Virus Infection and Factors Associated With Sustained Virologic Response

Gastroenterology, 2016
Norah A Terrault, Adrian M Di Bisceglie, Alexander Kuo   +2 more
exaly  

Ledipasvir plus sofosbuvir as salvage therapy for HCV genotype 1 failures to prior NS5A inhibitors regimens

Journal of Medical Virology, 2017
Norio Akuta, Hitomi Sezaki, Yusuke Kawamura   +2 more
exaly  

Ledipasvir/sofosbuvir with or without ribavirin for 8 or 12 weeks for the treatment of HCV genotype 4 infection: results from a randomised phase III study in Egypt

Gut, 2019
Gamal E Shiha, Gamal Esmat, Mohamed Hassany   +2 more
exaly  

Ledipasvir–sofosbuvir for 6 weeks to treat acute hepatitis C virus genotype 1 or 4 infection in patients with HIV coinfection: an open-label, single-arm trial

The Lancet Gastroenterology and Hepatology, 2017
Sanjay Bhagani, Patrick Ingiliz, Christoph Boesecke   +2 more
exaly